- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03689530
Using Peer Support to Aid in Prevention and Treatment in Prediabetes (UPSTART)
UPSTART: Using Peer Support to Aid in Prevention and Treatment in Prediabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The intervention seeks to address the need to test in routine primary care evidence-based approaches to increase uptake, engagement, and maintenance of healthy behaviors necessary to decrease progression to diabetes among primary care patients with prediabetes, especially low-income and racial and ethnic minority adults with prediabetes. The study will conduct a parallel, two-armed, randomized controlled pragmatic clinical trial including adults with prediabetes at two primary care centers in two different health systems: Kaiser Permanente Northern California and the University of Michigan Health System. Each health system received IRB approval from its own IRB to accommodate site-specific nuances in its implementation. The trial will evaluate whether adding a 12-month predominantly telephone-based volunteer peer support program (UPSTART) to health care provider counseling and referral to diabetes prevention programs leads to greater improvements in A1c, the weight loss, and waist circumference than health care provider counseling and referral alone (Aim 1). The study will also compare differences in reported physical activity, diet, and enrollment and engagement in diabetes prevention programs as potential mediators as well as autonomous motivation, behavior-specific self-efficacy, patient activation, and perceived support; and moderators such as health literacy (Aim 2). To enhance adoption of the intervention by the two study health systems and dissemination to other health systems if effective, the study will evaluate costs and use an integrated RE-AIM and Consolidated Framework for Implementation Research (CFIR) framework to evaluate processes of intervention implementation in the two primary care settings (Aim 3). The study duration will be 5 years, to allow for peer supporter and patient recruitment, completion of the 12-month program, and assessment of outcomes at 6 months and at 12 months.
The study will use mixed methods-i.e., the collection, analysis, and combining of both quantitative and qualitative data-to investigate elements important for implementation and dissemination. The study will gather data on how peer supporters, primary care clinic staff, and patients experience the intervention and how the experiences of participants together with the trial's results suggest the study should modify the intervention. Using this approach, the study aim to ensure that the intervention has the greatest possible likelihood of adoption in both UMHS and KPNC health systems should the study find it has positive effects on processes and outcomes of care. The UPSTART intervention is designed for peers to interact and provide support in a way that is autonomy supportive with the goal of enhancing autonomous motivation and self-efficacy for healthy behaviors. The study will hold periodic initial trainings for new peer supporters over the study period. In addition, peer supporters will receive: 1) routine, structured check-ins that will include monthly peer support group meetings (with option to call in) to allow exchange; 2) back-up support: offering peer supporters contact information for staff who they can call; and 3) continuing education and booster training at the monthly group meetings to enrich their skill sets and knowledge.
The peer supporters were included in the total number of participant numbers for the trial and in the intervention arm in the study flow portion of this record because they were consented. Demographic characteristics of the peer supporters are also reported. However, they were not randomized; they were recruited to deliver the intervention to recruited participants with prediabetes whose outcomes we aimed to improve through the delivered intervention. The peer supporters' involvement was to deliver the intervention to the participants who were randomized to either receive the peer support intervention or to enhanced usual care. The study consented the peer supporters because they completed surveys at three time points; the intent was to look at whether delivering the intervention affected the peer supporters' own reported behaviors as exploratory only. There was and is no intention to compare coach data to primary, secondary, or any other outcome measures of the randomized participants in the trial.
During the trial, another primary care center within the University of Michigan Health System was added. Because this center was within the University of Michigan Health System, and all contact information was identical, there was no reason to add another participating site.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Oakland, California, United States, 94611
- Kaiser Permanente Northern California
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-2800
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Peer supporter:
- prior A1c 5.7 - 6.4 in last 3 years, with most recent being either lass than 5.7 or 0.4 points less than prior; AND/OR
- prior BMI >=25 or >=23 if Asian American in last three years with most recent 2% lower body weight;AND/OR
- prior completion of a wellness or diabetes prevention program; AND/OR
- completion of initial 6 months of UPSTART intervention as participant.
Patient participant:
- no prior dx of DM or current use of anti-hyperglycemic medication;
- BMI >=25 m2/kg or >=23 if Asian; and
- A1c 5.7 - 6.4.
Exclusion Criteria:
- serious psychiatric disorder in past 24 months
- pregnant or planning pregnancy
- substance abuse in past 12 months
- diagnosis of dementia, bipolar, schizophrenia, personality disorder
- other serious concerns rendering possible development of diabetes unimportant to potential participant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Peer Support Arm.
Participants randomized to peer support will be matched with a peer supporter.
|
Participants will be paired with a peer supporter. They will meet in person one time and then be in contact by phone or texting on a weekly basis for the first 6 months of a year. During the final six months of the year, the peer supporter and participant will be in touch at least monthly. The peer supporter will help link participants to existing health system and community diabetes prevention programs, support their engagement in formal programs, maintain achieved gains, and support participants to initiate and sustain healthy behaviors to prevent diabetes. The 95 peer supporters who consented to participate in the study are included in this arm, along with the participants who were randomized to this arm, in the participant flow. The peer supporters were not randomized to the arm; rather, they consented to deliver the intervention. Although 95 consented, only 68 met with at least one peer, the first step in intervention delivery. |
Active Comparator: Enhanced Usual Care
Participants randomized to enhanced usual care will receive brief education and folder of information and resources.
|
Participants will receive brief education and folder of information and resources.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Glycosylated Hemoglobin A1c (HbA1c) at 6 Months
Time Frame: baseline to 6 months
|
An A1C test measures the percentage of red blood cells that have glucose-coated hemoglobin.
This percentage indicates average blood sugar levels over the last 2-3 months.
Higher percentages indicate higher levels of blood sugar levels, and an A1c between 5.7% and 6.4% is considered in the prediabetes range.
The negative numbers for change over time indicate an improvement because they show a drop in percentages from the baseline percentages.
|
baseline to 6 months
|
Change in Body Weight at 6 Months
Time Frame: baseline to 6 months
|
body weight in kilograms
|
baseline to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Glycosylated Hemoglobin A1c (HbA1c) at 12 Months
Time Frame: baseline through 12 months
|
An A1C test measures the percentage of red blood cells that have glucose-coated hemoglobin.
This percentage indicates average blood sugar levels over the last 2-3 months.
Higher percentages indicate higher levels of blood sugar levels, and an A1c between 5.7% and 6.4% is considered in the prediabetes range.
The negative numbers for change over time indicate an improvement because they show a drop in percentages from the baseline percentages.
|
baseline through 12 months
|
Change in Body Weight at 12 Months
Time Frame: baseline through 12 months
|
body weight in kilograms
|
baseline through 12 months
|
Change in Whether Participant Enrolled in a Formal Program to Prevent Diabetes
Time Frame: baseline through 12 months
|
one item with yes/no response.
Results indicate percentage of participants who responded "yes."
|
baseline through 12 months
|
Change in Number of Sessions Participant Attended in a Formal Program to Prevent Diabetes
Time Frame: baseline through 12 months
|
one item that asks participant to report number of sessions attended
|
baseline through 12 months
|
Change in Frequency and Duration Participant Engages in Moderate to Vigorous Physical Activity as Shown by Minutes Per Week
Time Frame: baseline through 12 months
|
This combined measure is based on participant-reported frequency and duration of moderate to vigorous physical activity, measured in minutes per week. Frequency and duration were initially registered separately. Two questions were used to calculated minutes of physical activity per week, asked in both the baseline and 12 months surveys: Q1. On average, how many days per week do you engage in moderate-to-vigorous physical activity? A1: 0-7, integer response only Q2: On average on those days, how many minutes do you engage in physical activity as this level? A2: open numeric response A1*A2 = minutes per week (Physical Activity value) Minutes of physical activity per week reported in 12 month survey - minutes of physical activity per week in baseline survey = change in minutes per week of physical activity |
baseline through 12 months
|
Change in the Number of Times Drinking Regular Soda or Pop That Contains Sugar
Time Frame: baseline through 12 months
|
Recorded frequency of consumption in the last 30 days.
Participants could report times per day, times per week, or times over past 30 days.
These reports were converted to the number of times over past 30 days participants drank regular soda or pop that contained sugar.
|
baseline through 12 months
|
Change in Patient Activation as Measured by the Patient Activation Measure 13 (PAM-13)
Time Frame: baseline through 12 months
|
PAM-13 is a 13-item scale that measures participant beliefs, perceived knowledge, and confidence for engaging in behaviors related to the participant's health condition.
PAM-13 has a 0-100 scale, where a low score indicates low activation (disengaged and overwhelmed) and a high score indicates high activation (patient considers self their own advocate).
The difference between the score at 12 months and the score at baseline was calculated.
|
baseline through 12 months
|
Change in Participant's Perceived Confidence in Their Ability to Take Steps to Prevent Diabetes Using the Williams Perceived Competence Scale
Time Frame: baseline through 12 months
|
Williams Perceived Competence Scale comprises 4 items measuring the participants' perception of their own ability to take steps to prevent diabetes.
Responses for each individual question range from 1 (not at all true) to 7 (very true).
The responses to all 4 items were averaged (range: 1-7), with higher scores on the scale indicating higher perceived competence in preventing diabetes.
|
baseline through 12 months
|
Change in Autonomous Motivation to Prevent Diabetes Using the Treatment Self-Regulation Questionnaire (TSRQ - Autonomous)
Time Frame: baseline through 12 months
|
The Treatment Self-Regulation Questionnaire (TSRQ) consisted of 11 items that measured the participants' perceptions of how true various reasons to take steps to help prevent diabetes may be to the participants. The TSRQ was split into two measures: autonomous and controlled. The autonomous measure consisted of 4 items that measured participants' autonomous (or internal) perceptions of how true various reasons to take steps to help prevent diabetes may be to the participants. Responses for each individual question range from 1 (not at all true) to 7 (very true). The responses to all 4-items are averaged (range: 1-7). Higher scores indicate participants agree with more internal reasons for preventing diabetes (ex: wanting to take responsibility for my own health). |
baseline through 12 months
|
Change in the Participant's Level of Social Support Related to Improving Their Own Health Behaviors Using the Change in Health-Specific Social Support Scale
Time Frame: baseline through 12 months
|
The Health-Specific Social Support Scale consisted of 12 items that asked participants to indicate their level of agreement on a 6-point Likert scale ("Strongly disagree" [1] to "Strongly agree" [6]) with statements regarding accessibility of any contact they had with people in the past 3 months who were specifically also at risk for developing diabetes and could provide social support in attempts to prevent diabetes via healthy lifestyle changes.
Scores for negative statements were reversed, and the total score was the sum of all scores.
Total scores can range from 12 (minimum) to 72 (maximum).
A higher score indicated a better outcome because it indicated a higher level of reported social support.
|
baseline through 12 months
|
The Role a Participant's Peer Supporter Played in Assisting Them to Set and Reach Their Goals Using the Goal Setting and Intervention Tailoring Subscale of the Patient Assessment of Chronic Illness Care (PACIC) at 6 Months
Time Frame: 6 months
|
The goal setting and intervention tailoring subscale of the Patient Assessment of Chronic Illness Care (PACIC) consisted of 5 questions that ask the participant to state how often their peer supporter engaged in supportive behaviors regarding setting and achieving goals in order to make healthy lifestyle changes.
Each question had a range of 1 (None of the time) to 5 (Always).
Averaged scores range from 1 (minimum) to 5 (maximum).
A higher score indicated a better outcome because it indicated that the peer perceived their partner to be more supportive.
|
6 months
|
The Role a Participant's Peer Supporter Played in Assisting Them to Set and Reach Their Goals Using the Goal Setting and Intervention Tailoring Subscale of the Patient Assessment of Chronic Illness Care (PACIC) at 12 Months
Time Frame: 12 months
|
The goal setting and intervention tailoring subscale of the Patient Assessment of Chronic Illness Care (PACIC) consisted of 5 questions that ask the participant to state how often their peer supporter engaged in supportive behaviors regarding setting and achieving goals in order to make healthy lifestyle changes.
Each question had a range of 1 (None of the time) to 5 (Always).
Averaged scores range from 1 (minimum) to 5 (maximum).
A higher score indicated a better outcome because it indicated that the peer perceived their partner to be more supportive.
|
12 months
|
Participant's Perceived Autonomy Support From Their Peer Supporter Using the Health Care Climate Questionnaire (HCCQ, Long Form) at 6 Months
Time Frame: 6 months
|
The Health Care Climate Questionnaire (HCCQ, long form) consisted of 15 items that asked the participant to rank their agreement with statements that indicated degree of autonomy support (Strongly Disagree [1] to Strongly Agree [7]).
Averaged scores ranged from 1 (minimum) to 7 (maximum).
A higher the score indicated a better outcome because it indicated that the peer perceived their partner to be more autonomy supportive.
|
6 months
|
Participant's Perceived Autonomy Support From Their Peer Supporter Using the Health Care Climate Questionnaire (HCCQ, Long Form) at 12 Months
Time Frame: 12 months
|
The Health Care Climate Questionnaire (HCCQ, long form) consisted of 15 items that asked the participants to rank their agreement with statements that indicated degree of autonomy support (Strongly Disagree [1] to Strongly Agree [7]).
Total scores ranged from 1 (minimum) to 7 (maximum).
A higher score indicated a better outcome because it indicated that the peer perceived their partner to be more autonomy supportive.
|
12 months
|
Change in the Number of Times Drinking Sugary Drinks Besides Pop or Soda
Time Frame: baseline through 12 months
|
Recorded frequency of consumption in the last 30 days.
Participants could report times per day, times per week, or times over past 30 days.
These reports were converted to the number of times over past 30 days participants drank sugary drinks besides pop or soda.
|
baseline through 12 months
|
Change in the Number of Times Eating Fruit
Time Frame: baseline through 12 months
|
Recorded frequency of consumption in the last 30 days - participants could report times per day, times per week, or times over past 30 days, which was converted to times over past 30 days
|
baseline through 12 months
|
Change in the Number of Times Eating Vegetables
Time Frame: baseline through 12 months
|
One measure that recorded frequency of consumption in the last 30 days - participants could report times per day, times per week, or times over past 30 days, which was converted to times over past 30 days
|
baseline through 12 months
|
Change in the Number of Times Eating Meals Cooked With Olive Oil
Time Frame: baseline through 12 months
|
One measure that recorded frequency of consumption in the last 30 days - participants could report times per day, times per week, or times over past 30 days, which was converted to times over past 30 days
|
baseline through 12 months
|
Change in the Number of Times Eating Sweets or Desserts
Time Frame: baseline through 12 months
|
One measure that recorded frequency of consumption in the last 30 days - participants could report times per day, times per week, or times over past 30 days, which was converted to times over past 30 days
|
baseline through 12 months
|
Change in the Number of Times Eating Whole Grain Breads, Whole Grain Pasta, or Brown Rice
Time Frame: baseline through 12 months
|
One measure that recorded frequency of consumption in the last 30 days - participants could report times per day, times per week, or times over past 30 days, which was converted to times over past 30 days
|
baseline through 12 months
|
Change in the Number of Times Eating Breads, Pasta, Rolls, or Rice Made From White, Refined Grains
Time Frame: baseline through 12 months
|
One measure that recorded frequency of consumption in the last 30 days - participants could report times per day, times per week, or times over past 30 days, which was converted to times over past 30 days
|
baseline through 12 months
|
Change in Controlled Motivation to Prevent Diabetes Using the Treatment Self-Regulation Questionnaire (TSRQ - Controlled)
Time Frame: baseline through 12 months
|
The Treatment Self-Regulation Questionnaire (TSRQ) consists of 11 items that measure participants' perceptions of how true various reasons to take steps to help prevent diabetes may be to the participants. The TSRQ is split into two measures: autonomous and controlled. The controlled measure consists of 7 items that measure participants' controlled (or external) perceptions of how true various reasons to take steps to help prevent diabetes may be to the participants. Responses for each individual question range from 1 (not at all true) to 7 (very true). The responses to all 7-items are averaged (range: 1-7). Higher scores indicate participants agree with more external behaviors or reasons for preventing diabetes (ex: feeling pressure to do so from others). |
baseline through 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mary Elllen M Heisler, MD, University of Michigan
- Principal Investigator: Julie A Schmittdiel, PhD, Kaiser Permanente
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00135745
- 1R18DK113403-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PreDiabetes
-
Aga Khan UniversityLinnaeus University; Kenyatta UniversityRecruiting
-
Philip KernNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Chonbuk National University HospitalCompletedPreDiabetes
-
TNOWageningen University and Research; Google LLC.; Jumbo Supermarkten Bv.; Noldus...Completed
-
University of TorontoInternational Nut and Dried Fruit Council (INC); The National Dried Fruit Trade... and other collaboratorsUnknown
-
National Yang Ming UniversityRecruiting
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Clinical Nutrition Research Centre, SingaporeSingapore Institute for Clinical SciencesCompleted
-
Northwestern UniversityAllianceChicago; Erie Family Health CentersCompleted
-
Ohio UniversityTouro University, CaliforniaCompletedPreDiabetes
Clinical Trials on Peer Support
-
Northwestern UniversityCompletedDepressionUnited States
-
Makerere UniversityUniversity of Bergen; Centre MurazUnknownMalnutrition | Neurologic Deficits | Poor Performance Status | Infections, Hospital | Mixed Behavior and Emotional DisorderUganda
-
University of Eastern FinlandSocial Insurance Institution, Finland; Finnish Cultural FoundationRecruiting
-
Lighthouse TrustUniversity of North Carolina, Chapel Hill; World Health Organization; Kamuzu... and other collaboratorsUnknown
-
Universitätsklinikum Hamburg-EppendorfUniversity of UlmActive, not recruitingSevere Mental Health Condition With Indication of Hospital AdmissionGermany
-
MRC/UVRI and LSHTM Uganda Research UnitKarolinska Institutet; University of California, San Francisco; European and... and other collaboratorsRecruitingHIV-1-infectionUganda
-
Hospices Civils de LyonRecruiting
-
Ohio State UniversityCambia Health FoundationEnrolling by invitationDementia | Family Caregiver | Peer SupportUnited States
-
University of JyvaskylaHelsinki University Central HospitalCompleted
-
San Diego State UniversityAmerican Academy of Family Physicians; Peers for ProgressUnknown